- Report
- March 2024
- 184 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- March 2024
- 180 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- April 2024
- 182 Pages
Global
From €5260EUR$5,450USD£4,512GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- January 2024
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- March 2024
- 200 Pages
Global
From €4006EUR$4,150USD£3,436GBP
- Report
- January 2024
- 200 Pages
Global
From €4006EUR$4,150USD£3,436GBP
- Report
- January 2022
- 200 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- January 2022
- 60 Pages
Global
From €3813EUR$3,950USD£3,270GBP
- Report
- January 2022
- 60 Pages
Global
From €3813EUR$3,950USD£3,270GBP
- Report
- January 2022
- 200 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Clinical Trials
- December 2019
- 635 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- June 2018
- 49 Pages
Global
From €3373EUR$3,495USD£2,894GBP
- Report
- April 2023
- 94 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- May 2022
- 54 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- February 2024
- 155 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- April 2023
- 147 Pages
Global
From €5790EUR$5,999USD£4,967GBP
Acute Coronary Syndrome (ACS) is a term used to describe a range of conditions caused by a sudden decrease in blood flow to the heart. This can lead to chest pain, heart attack, and other cardiovascular complications. ACS is a major cause of death and disability worldwide.
The ACS drug market is a subset of the larger cardiovascular drug market. It includes drugs used to treat ACS, such as antiplatelet agents, anticoagulants, and statins. These drugs are used to reduce the risk of further complications and improve patient outcomes. Additionally, drugs used to treat the symptoms of ACS, such as pain medications, are also included in this market.
The ACS drug market is highly competitive, with many large pharmaceutical companies offering a range of products. Some of the major players in this market include Pfizer, Merck, Sanofi, Bristol-Myers Squibb, and Novartis. Show Less Read more